Nurx Review

Nurx — Provider Profile

Overview

Nurx is a telehealth platform founded in 2015, originally built around birth control and PrEP prescriptions. The company was acquired by Thirty Madison in 2022 — the same parent company behind Keeps (hair loss) and Cove (migraine). Thirty Madison operates a "condition-specific brands" model, and while Nurx's core remains reproductive health, the platform expanded into weight management in 2023 with compounded GLP-1 medications.

April 2026 context: This provider is active and prescribing brand-name GLP-1 medications. Orforglipron (Eli Lilly oral GLP-1) is not yet FDA-approved — PDUFA date April 10, 2026. Medicare GLP-1 Bridge coverage for obesity is pending; not yet in effect. Compounded semaglutide supply is declining under FDA enforcement pressure.

Nurx has strong brand recognition among women, built over years of providing accessible reproductive healthcare. The company is now leveraging that existing patient trust to cross-sell weight management services — a common playbook among telehealth platforms looking to expand revenue, but one that means Nurx is relatively newer to obesity care than dedicated weight management competitors.

Medications Offered

• Wegovy (semaglutide) — GLP-1 receptor agonist, weekly subcutaneous injection, FDA-approved for chronic weight management
• Wegovy HD (semaglutide 7.2mg) — Higher-dose Wegovy formulation, weekly subcutaneous injection
• Zepbound (tirzepatide) — Dual GIP/GLP-1 receptor agonist, weekly subcutaneous injection, FDA-approved for chronic weight management
• Orforglipron (oral GLP-1) — Daily oral GLP-1 receptor agonist, $149/mo
• Metformin — Oral medication for weight management support

Pricing

True monthly cost: $150/month for compounded semaglutide or $250/month for compounded tirzepatide. The all-in pricing is straightforward — there is no separate membership or consultation fee on top of the medication cost. This makes Nurx easy to compare against competitors: what you see is what you pay.

At $150/month for compounded semaglutide, Nurx is roughly in line with Ro ($149) and Henry Meds ($149), though it lacks the clinical extras that some competitors include (dietitians, video visits, lab work).

States Served

Available in 33 US states. This is more limited than most major competitors — Mochi Health covers 49 states, Hims covers all 50, and Ro covers 50. Check the Nurx website for current state availability before starting the onboarding process.

Insurance

• Insurance is not accepted for the weight management program — cash-pay only
• HSA/FSA cards are accepted
• No prior authorization support (since no brand-name GLP-1s are offered)
• Nurx does accept insurance for some of its other services (birth control, PrEP), but the GLP-1 program is entirely out of pocket

Consultation Process

Model: Async questionnaire only — no video consultations.

1. Complete an online health assessment covering weight history, medical conditions, and treatment goals
2. A licensed provider reviews the questionnaire (usually within 24 hours)
3. If clinically appropriate, a prescription is issued
4. Medication ships directly to your door
5. Ongoing messaging with the care team is included for follow-up questions and check-ins

There are no video consultations, no dietitian access, and no lab work included. The care model is lean — you get a prescription and messaging support, but not the kind of structured clinical program offered by Mochi Health, Calibrate, or Sequence.

Pros

• Simple all-in pricing with no separate membership fee — $150/month for semaglutide, $250/month for tirzepatide
• Both compounded semaglutide and compounded tirzepatide available
• Strong women's health reputation built over a decade of telehealth services
• Easy onboarding process with fast provider turnaround (typically within 24 hours)
• Backed by Thirty Madison, a well-funded parent company — less startup risk than smaller competitors
• Ongoing messaging with care team included at no extra cost

Cons

• Available in only 33 states — significantly more limited than competitors covering 49-50 states
• No brand-name GLP-1 medications offered (no Ozempic, Wegovy, Mounjaro, or Zepbound)
• Async-only consultations — no video visits with providers
• No dietitian access, nutritional coaching, or structured lifestyle support
• No lab work included or coordinated through the platform
• Insurance not accepted for the weight management program
• Relatively new to weight management (entered the space in 2023) compared to dedicated obesity platforms
• No clinical specialists in obesity medicine — general providers handle consultations

Best For

Patients who want a simple, no-frills compounded GLP-1 prescription at a transparent monthly price without dealing with separate membership fees. Nurx is particularly appealing if you are already a Nurx patient for reproductive health services and want to add weight management with a platform you already know and trust. The streamlined async process suits patients who prefer convenience over clinical depth.

Editorial Verdict

Nurx offers a clean, uncomplicated entry point into compounded GLP-1 treatment. The all-in pricing ($150/month for semaglutide, $250/month for tirzepatide) is competitive and refreshingly transparent — no membership fees, no hidden costs, no price tiers to decode. For patients who simply want a prescription and ongoing messaging support, Nurx delivers that without unnecessary complexity.

The trade-offs are real, though. The 33-state limitation immediately disqualifies a meaningful portion of potential patients. The async-only model means you never speak face-to-face with a provider, and there is no dietitian, no coaching, and no lab coordination — services that platforms like Mochi Health include at comparable or slightly higher price points. The absence of brand-name GLP-1 options also means Nurx cannot serve patients whose insurance might cover Wegovy or Zepbound.

Nurx's strongest asset may be its existing patient base. If you already trust Nurx from years of reproductive health care, the barrier to trying their weight management program is low. But if you are evaluating GLP-1 providers from scratch, the limited state coverage and bare-bones clinical model make it harder to recommend over competitors like Ro (similar pricing, 50-state coverage) or Mochi Health (more clinical depth for modestly more money).

Related Content

• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• Cheapest GLP-1 Providers — Budget options compared
• GLP-1 Cost & Insurance FAQ — What you'll actually pay